Evidence map›Paper›PMID 38332389›Full record

ArticlePharmaceutical research2024

Structure Based Machine Learning Prediction of Retention Times for LC Method Development of Pharmaceuticals.

Jonathan Fine, Amanda K Peterson Mann, Pankaj Aggarwal

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jonathan FineAnalytical Research & Development, MRL, Merck & Co., Inc., Rahway, NJ, 07065, USA.
Amanda K Peterson MannAnalytical Research & Development, MRL, Merck & Co., Inc., Rahway, NJ, 07065, USA.
Pankaj AggarwalAnalytical Research & Development, MRL, Merck & Co., Inc., Rahway, NJ, 07065, USA. pankaj.aggarwal@merck.com.ORCID http://orcid.org/0009-0005-0344-5886

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSignificant resources are spent on developing robust liquid chromatography (LC) methods with optimum conditions for all project in the pipeline. Although, data-driven computer assisted modelling has been implemented to shorten the method development timelines, these modelling approaches require project-specific screening data to model retention time (RT) as function of method parameters. Sometimes method re-development is required, leading to additional investments and redundant laboratory work. Cheminformatics techniques have been successfully used to predict the RT of metabolites & other component mixtures for similar use cases. Here we will show that these techniques can be used to model structurally diverse molecules and predictions of these models trained on multiple LC conditions can be used for downstream data-driven modelling.

methodsThe Molecular Operating Environment (MOE) was used to calculate over 800 descriptors using the strucutres of the analytes. These descriptors were used to model the RT of the analytes under four chromatographic conditions. These models were then used to create data-driven models using LC-SIM.

resultsA structural-based Random Forest (RF) model outperformed other techniques in cross-validation studies and predicted the RTs of a randomized test set with a median percentage error less than 4% for all LC conditions. RTs predicted by this structure-based model were used to fit a data-driven model that identifies optimum LC conditions without any additional experimental work.

conclusionsThese results show that small training sets yield pharmaceutically relevant models when used in a combination of structure-based and data-driven model.

Indexed as

Chromatography, LiquidComputer SimulationPharmaceutical PreparationsPharmaceutical PreparationsChromatographyMachine learningMethod developmentQSRR

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.